Samantha DeMarsh

Samantha DeMarsh

Auto-generated profile, based on publicly available information

Samantha DeMarsh

Nationwide Children's Hospital

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Pediatrics
Verified
Journal Article
Closed access
PDF file
SDSamantha DeMarsh
Samantha DeMarsh
AHAnneliese Huntzinger
Anneliese Huntzinger
AGAlison Paige Gehred
Alison Paige Gehred
JSJoseph R. Stanek
Joseph R. Stanek
KKKathi Kemper
Kathi Kemper
JBJennifer Belsky
Jennifer Belsky
CONTEXT: A common reproach precluding the use of osteopathic manipulative medicine (OMM) in pediatrics is a lack of evidence regarding its safety, feasibility, and effectiveness. OBJECTIVE: We conducted a systematic, scoping review of pediatric osteopathic medicine to identify gaps in the literature and make recommendations for future research. DATA SOURCES: We searched 10 databases using 6 key words and medical subject heading terms for any primary articles reporting OMM use in children published from database inception until initiation of the study. STUDY SELECTION: Articles were selected if they reported primary data on OMM conducted in the United States on patient(s) 0 to 18 years old. DATA EXTRACTION: Baseline study characteristics were collected from each article and the Grading of Recommendations, Assessment, Development, and Evaluations system was used to critically appraise each study. RESULTS: Database search yielded 315 unique articles with 30 studies fulfilling inclusion and exclusion criteria. Of these, 13 reported the data required to demonstrate statistically significant results, and no significant adverse events were reported. The majority of studies were graded as providing weak clinical evidence because of significant methodologic flaws and biases. LIMITATIONS: The review was limited to US-based studies and reports. Minimal discrepancies between reviewers were resolved via an objective third reviewer. CONCLUSIONS: There is little strong, scientific, evidence-based literature demonstrating the therapeutic benefit of OMM for pediatric care. No strong clinical recommendations can be made, but it can be medically tolerated given its low risk profile. High-quality, scientifically rigorous OMM research is required to evaluate safety, feasibility, and efficacy in pediatrics.

1 March 2021 in Resuscitation Plus
Verified
Journal Article
Open access
SDSamantha J. DeMarsh
Samantha J. DeMarsh
ZSZubin S. Shah
Zubin S. Shah
AOAhmed F. Osman
Ahmed F. Osman
We report a full-term male neonate found to have undiagnosed syngnathia requiring extensive resuscitation at birth followed by urgent tracheostomy. We conducted a systematic literature review to study the presentation, resuscitation methods, and outcomes of neonates with congenital syngnathia. Of the 174 cases reported to date, 91 had initial resuscitation data available. Extensive resuscitation was required in 16 of these 91 infants (18%). This ranged from nasal intubation to emergent tracheostomy. These neonates are potentially higher risk deliveries for which methods in addition to those recommended by the American Heart Association neonatal resuscitation guidelines may be needed.

1 February 2018 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
EKErica C Kaye
Erica C Kaye
CGCourtney Gushue
Courtney Gushue
SDSamantha Demarsh
Samantha Demarsh
JJJonathan Jerkins
Jonathan Jerkins
JSJennifer Snaman
Jennifer Snaman
JBJustin N. Baker
Justin N. Baker

20 February 2022 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
SDSamantha J. DeMarsh
Samantha J. DeMarsh
NKNicole E. Kendel
Nicole E. Kendel
CBChristine Bacha
Christine Bacha
SAStacy P. Ardoin
Stacy P. Ardoin
SKSamir Kahwash
Samir Kahwash
MRMelissa J. Rose
Melissa J. Rose
Castleman disease is a non‐clonal, lymphoproliferative disorder rarely seen in children. Presented is a 12‐year‐old male with progressive abdominal pain, vomiting, and fever. Diagnostic testing revealed multi‐organ system involvement and the diagnosis was ultimately made with tissue biopsy. Marked disease regression occurred after high‐dose steroids and continued interleukin‐6 inhibition.

31 January 2024
Verified
Preprint
Open access
SDSamantha DeMarsh
Samantha DeMarsh
NKNicole Kendall
Nicole Kendall
CBChristine Bacha
Christine Bacha
SAStacy Ardoin
Stacy Ardoin
MRMelissa Rose
Melissa Rose
Castleman Disease is a rare non-clonal lymphoproliferative disorder that predisposes towards adults with very few reported cases in children. Presented is a 12-year-old male with progressive abdominal pain, vomiting, and fever. Laboratory testing showed elevated inflammatory markers, hemolysis, kidney injury, coagulopathy, thrombocytopenia, and refractory hypocalcemia. Imaging demonstrated an adrenal mass, hepatosplenomegaly, generalized lymphadenopathy, and increased bone marrow uptake without focality. The diagnosis of Castleman Disease was made with tissue biopsy and marked disease regression occurred after high dose steroids and interleukin-6 inhibition. Awareness of Castleman disease in a pediatric patient is essential to providing adequate and timely care.